India Generics Makers Keep Troubled Eye On FTA Negotiations With EU
This article was originally published in PharmAsia News
Executive Summary
India's makers of generic drugs are keeping a close watch on the Free Trade Agreement with the European Union now reaching a key stage, with stronger intellectual property rights protections on the table.